Responses
Regular and Young Investigator Award Abstracts
Tumor and Stromal Cell Biology
1440 Arginase-1 peptide-based vaccine is an exciting approach to modulate the tumor microenvironment and drive efficacy in preclinical tumor models
Compose a Response to This Article
Other responses
No responses have been published for this article.